EXHIBIT LJoint Filing Agreement • July 5th, 2001 • Soros Fund Management LLC • Biological products, (no disgnostic substances)
The undersigned hereby agree that the statement on Schedule 13D with respect to the Common Stock of Integra LifeSciences Holdings Corporation (the "Issuer"), dated as of July 5, 2001, is, and any amendments thereto (including amendments on Schedule 13G) signed by each of the undersigned shall be, filed on behalf of each of us pursuant to and in accordance with the provisions of Rule 13d-1(k) under the Securities Exchange Act of 1934.
